REPOSITRAK ($TRAK) posted quarterly earnings results on Thursday, May 15th. The company reported earnings of $0.10 per share, beating estimates of $0.09 by $0.01. The company also reported revenue of $5,910,000, missing estimates of $6,120,000 by $-210,000.
You can see Quiver Quantitative's $TRAK stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
REPOSITRAK Insider Trading Activity
REPOSITRAK insiders have traded $TRAK stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.
Here’s a breakdown of recent trading of $TRAK stock by insiders over the last 6 months:
- RANDALL K FIELDS (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 50 sales selling 187,500 shares for an estimated $3,974,736.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
REPOSITRAK Hedge Fund Activity
We have seen 36 institutional investors add shares of REPOSITRAK stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ASHFORD CAPITAL MANAGEMENT INC added 408,871 shares (+inf%) to their portfolio in Q1 2025, for an estimated $8,287,815
- RICE HALL JAMES & ASSOCIATES, LLC removed 74,295 shares (-8.0%) from their portfolio in Q1 2025, for an estimated $1,505,959
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 41,486 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $840,921
- ACUITAS INVESTMENTS, LLC removed 32,600 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $660,802
- ELLSWORTH ADVISORS, LLC added 28,292 shares (+inf%) to their portfolio in Q4 2024, for an estimated $626,101
- INVESCO LTD. removed 27,764 shares (-11.2%) from their portfolio in Q1 2025, for an estimated $562,776
- NEWEDGE ADVISORS, LLC removed 25,011 shares (-26.8%) from their portfolio in Q4 2024, for an estimated $553,493
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
